Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
作者： Wendy De Roock , Bart Claes , David Bernasconi , Jef De Schutter , Bart Biesmans
DOI: 10.1016/S1470-2045(10)70130-3
关键词:
摘要: BACKGROUND: Following the discovery that mutant KRAS is associated with resistance to anti-epidermal growth factor receptor (EGFR) antibodies, the tumours of patients with metastatic colorectal cancer are now profiled for seven KRAS mutations before receiving cetuximab or panitumumab. However, most patients with KRAS wild-type tumours still do not respond. We studied the effect of other downstream mutations on the efficacy of cetuximab in, to our knowledge, the largest cohort to date of patients with chemotherapy-refractory …
kuleuven.be
auth.gr
elsevier.com
lancet.com 参考文章(33)
Werner Scheithauer, Alois Lang, Thomas Winder, K-ras mutations and cetuximab in colorectal cancer. The New England Journal of Medicine. ,vol. 360, pp. 834- 834 ,(2009)
J Souglakos, J Philips, R Wang, S Marwah, M Silver, M Tzardi, J Silver, S Ogino, S Hooshmand, E Kwak, E Freed, J A Meyerhardt, Z Saridaki, V Georgoulias, D Finkelstein, C S Fuchs, M H Kulke, R A Shivdasani, Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. British Journal of Cancer. ,vol. 101, pp. 465- 472 ,(2009) , 10.1038/SJ.BJC.6605164
Nicola Personeni, Steffen Fieuws, Hubert Piessevaux, Gert De Hertogh, Jef De Schutter, Bart Biesmans, Wendy De Roock, An Capoen, Maria Debiec-Rychter, Jean-Luc Van Laethem, Marc Peeters, Yves Humblet, Eric Van Cutsem, Sabine Tejpar, Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab : A fluorescent in situ hybridization study Clinical Cancer Research. ,vol. 14, pp. 5869- 5876 ,(2008) , 10.1158/1078-0432.CCR-08-0449
L. Zhao, P. K. Vogt, Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanisms Proceedings of the National Academy of Sciences of the United States of America. ,vol. 105, pp. 2652- 2657 ,(2008) , 10.1073/PNAS.0712169105
Marc Peeters, Kelly S. Oliner, Alex Parker, Jing Huang, Salvatore Siena, Yves Humblet, Jean-Luc Van Laethem, Thierry André, Jeffrey Wiezorek, David Reese, Scott D. Patterson, Eric Van Cutsem, Abstract LB-174: Use of massively parallel, next-generation sequencing to identify gene mutations beyondERASthat predict response to panitumumab in a randomized, phase 3, monotherapy study of metastatic colorectal cancer (mCRC) Cancer Research. ,vol. 70, ,(2010) , 10.1158/1538-7445.AM10-LB-174
Hans Prenen, Jef De Schutter, Bart Jacobs, Wendy De Roock, Bart Biesmans, Bart Claes, Diether Lambrechts, Eric Van Cutsem, Sabine Tejpar, PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer. Clinical Cancer Research. ,vol. 15, pp. 3184- 3188 ,(2009) , 10.1158/1078-0432.CCR-08-2961
Andrea Sartore-Bianchi, Federica Di Nicolantonio, Michele Nichelatti, Francesca Molinari, Sara De Dosso, Piercarlo Saletti, Miriam Martini, Tiziana Cipani, Giovanna Marrapese, Luca Mazzucchelli, Simona Lamba, Silvio Veronese, Milo Frattini, Alberto Bardelli, Salvatore Siena, Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer PLoS ONE. ,vol. 4, pp. e7287- 7287 ,(2009) , 10.1371/JOURNAL.PONE.0007287
Nicola Normanno, Sabine Tejpar, Floriana Morgillo, Antonella De Luca, Eric Van Cutsem, Fortunato Ciardiello, Implications for KRAS status and EGFR-targeted therapies in metastatic CRC Nature Reviews Clinical Oncology. ,vol. 6, pp. 519- 527 ,(2009) , 10.1038/NRCLINONC.2009.111
Ludovic Barault, Nicolas Veyrie, Valerie Jooste, Delphine Lecorre, Caroline Chapusot, Jean-Marc Ferraz, Astrid Lièvre, Marion Cortet, Anne-Marie Bouvier, Patrick Rat, Patrick Roignot, Jean Faivre, Pierre Laurent-Puig, Francoise Piard, Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers International Journal of Cancer. ,vol. 122, pp. 2255- 2259 ,(2008) , 10.1002/IJC.23388
K S M Smalley, M Xiao, J Villanueva, T K Nguyen, K T Flaherty, R Letrero, P Van Belle, D E Elder, Y Wang, K L Nathanson, M Herlyn, CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations. Oncogene. ,vol. 28, pp. 85- 94 ,(2009) , 10.1038/ONC.2008.362